Publications 2013

AMIR 2013 Publications:

  1. Xu J, Vangveravong S, Li S, Fan J, Jones L.A, Cui J, Wang R, Tu Z, Chu W, Perlmutter JS, Mach RH. Positron emission tomography imaging of dopamine D2 receptors using a highly selective radiolabeled D2 receptor partial agonist. Neuroimage, 71:168-74, 2013.  PMCID: PMC3756817
  2. Saini R, Sorace AG, Warram JM, Mahoney M, Zinn KR, Hoyt K. An animal model allowing controlled receptor expression for molecular ultrasound imaging. Ultrasound in Medicine and Biology, 39: 172-180, 2013. PMCID: PMC3563100
  3. Sorace AG, Saini R, Rosenthal E, Warram JM, Zinn KR, Hoyt K. Optical fluorescent imaging to monitor temporal effects of microbubble-mediated ultrasound therapy. IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control, 60: 281-289, 2013. PMCID: PMC3628607
  4. Zhai G, Grubbs CJ, Stockard CR, Umphrey HR, Beasley TM, Kim H. Diffusion Weighted Imaging Evaluated the Early Therapy Effect of Tamoxifen in an MNU-Induced Mammary Cancer Rat Model. Plos One, vol. 8, pp. 1-7, 2013. PMCID: PMC3660312
  5. Kim H, Rigell CJ, Zhai G, Lee SK, Samuel SL, Martin A, Umphrey HR, Stockard CR, Beasley TM, Buchsbaum DJ, Li LS, Boothman DA, Zinn KR. Antagonistic effects of anti-EMMPRIN antibody when combined with chemotherapy against hypovascular pancreatic cancers. Molecular Imaging and Biology, Epub: 9 Jul 2013. PMID: 23836505
  6. Zhai G, Kim H, Samuel SL, Saver DB, Whitworth L, Zinn KR. Early therapy assessment of combined anti-DR5 antibody and carboplatin in triple-negative breast cancer xenografts in mice using diffusion-weighted imaging and 1H MR spectroscopy. Journal of Magnetic Resonance Imaging, Epub: 22 Oct 2013. PMID: 24151215
  7. Saini R, Sorace AG, Warram JM, Mahoney MJ, Zinn KR, Hoyt K. An animal model allowing controlled receptor expression for molecular ultrasound imaging. Ultrasound Med Biol 39(1):172-80, 2013. PMCID: PMC3563100
  8. Day KE, Beck LN, Heath H, Huang CC, Zinn KR, Rosenthal EL. Identification of the optimal therapeutic antibody for fluorescent imaging of cutaneous squamous cell carcinoma. Cancer Biol Ther 14(3), 2013. PMCID: PMC3595310
  9. Sorace A, Saini R, Rosenthal E, Warram J, Zinn KR, Hoyt K. Optical fluorescent imaging to monitor temporal effects of microbubble-mediated ultrasound therapy. EEE Trans Ultrason Ferroelectr Freq Control 60(2):281-9, 2013. PMCID: PMC3628607
  10. Kim H, Rigell CJ, Zhai G, Lee SK, Samuel SL, Martin A, Umphrey HR, Stockard CR, Beasley TM, Buchsbaum DJ, Li LS, Boothman DA, Zinn KR. Antagonistic Effects of Anti-EMMPRIN Antibody When Combined with Chemotherapy Against Hypovascular Pancreatic Cancers. Mol Imaging Biol. 2013 Jul 9. [Epub ahead of print] PMID: 23836505
  11. Rosenthal EL, Zinn KR. Putting Numbers to Fluorescent Guided Surgery. Mol Imaging Biol 15(6):647-8, 2013. PMID: 23836503
  12. Dugger KJ, Chrisman T, Jones B, Chastain P, Watson K, Estell K, Zinn K, Schwiebert L. Moderate aerobic exercise alters migration patterns of antigen specific T helper cells within an asthmatic lung. Brain Behav Immun 34:67-78, 2013. PMCID: PMC3826814
  13. Sweeny L, Hartman YE, Zinn KR, Prudent JR, Marshall DJ, Shekhani MS, Rosenthal EL. A novel extracellular drug conjugate significantly inhibits head and neck squamous cell carcinoma. Oral Oncol 49(10):991-7, 2013. PMID: 23920309.
  14. Day KE, Sweeny L, Kulbersh B, Zinn KR, Rosenthal EL. Preclinical Comparison of Near-Infrared-Labeled Cetuximab and Panitumumab for Optical Imaging of Head and Neck Squamous Cell Carcinoma. Mol Imaging Biol 15(6):722-9, 2013. PMID: 23715932
  15. Day KE, Beck LN, Deep NL, Kovar J, Zinn KR, Rosenthal EL. Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma. Laryngoscope 123(11):2681-9, 2013. PMCID: PMC3758788
  16. Heath CH, Deep NL, Beck LN, Day KE, Sweeny L, Zinn KR, Huang CC, Rosenthal EL. Use of panitumumab-IRDye800 to image cutaneous head and neck cancer in mice. Otolaryngol Head Neck Surg 148(6):982-90, 2013. PMID: 23525846
  17. Sorace AG, Warram JM, Mahoney M, Zinn KR, Hoyt K. Enhancement of adenovirus delivery after ultrasound-stimulated therapy in a cancer model. Ultrasound Med Biol 39(12): 2374-81, 2013. PMID 24063960
  18. Zhai G, Kim H, Sarver D, Samuel S, Whitworth L, Umphrey H, Oelschlager DK, Beasley TM, Zinn KR. Early therapy assessment of combined anti-DR5 antibody and carboplatin in triple-negative breast cancer models using diffusion-weighted imaging and 1H MR spectroscopy, J Magn Reson Imaging. 2013 Oct 22. doi: 10.1002/jmri.24319. [Epub ahead of print] PMID: 24151215

World Molecular Imaging Congress (WMIC) Presentations, Savannah, GA: September 18-21, 2013.

  1. Guihua, Z, Ayub A, Kim H, Samuel S, Chaudry I.  Evaluation of ethinyl estradiol (EE-3-SO4) in a rat model of traumatic brain injury using MRI and PET/CT. World Molecular Imaging Congress (WMIC), Savannah, GA, P226:September 18-21, 2013.
  2. Kim H, Samuel S, Zhai G, Rana S, Lee K, Martin A, Grubbs C, Zinn KR.  Dual combination therapy with anti-DR5 antibody and tamoxifen for triple negative breast cancer.  World Molecular Imaging Congress (WMIC), Savannah, GA, P250:September 18-21, 2013.
  3. Kim H, Rigell C, Zhai G, Lee K, Samuel S, Martin A, Umphrey H, Stockard CR, Beasley TM, Li LS, Boothman DA, Zinn KR.  Vascular-based personalized anti-EMMPRIN therapy for pancreatic cancer. World Molecular Imaging Congress (WMIC), Savannah, GA, P368:September 18-21, 2013.
  4. Sorace AG, Warram JM, Mahoney MJ, Zinn KR, Hoyt K.  Ultrasound-stimulated gene therapy for improved adenovirus infection. World Molecular Imaging Congress (WMIC), Savannah, GA, LBAP 146:September 18-21, 2013.
  5. Warram JM, Sorace AG, Mahoney MJ, Samuel S, Harbin B, Joshi M, Martin A, Whitworth L, Hoyt K, Zinn KR.  Biodistribution of P-selectin targeted microbubbles.  World Molecular Imaging Congress (WMIC), Savannah, GA, P106:September 18-21, 2013.
  6. Hoyt K, Sorace AG, Mahoney MJ, Zinn KR.  Detection of prostate tumor angiogenesis by volumetric molecular ultrasound imaging in an animal model. World Molecular Imaging Congress (WMIC), Savannah, GA, P569:September 18-21, 2013.
  7. Krell AM, Eby BT, Day K, Hartman YE, Zinn KR.  Increasing uptake of anti-EGFR antibody through modulation of EGFR expression. World Molecular Imaging Congress (WMIC), Savannah, GA, LBAP061:September 18-21, 2013.
  8. Bhattacharyya S, Patel N, Wei L, Riffle L, Kalen J, Hill GC, Jacobs PM, Zinn KR, Rosenthal EL.  Synthesis and evaluation of panitumumab-NIR dye conjugate as an immuno-fluorescence probe for HER1 expression in cancers. World Molecular Imaging Congress (WMIC), Savannah, GA, P230:September 18-21, 2013.
  9. Day K, Korb ML, Zinn KR, Rosenthal E.  Fluorescent imaging of labeled monoclonal antibodies for identification of oral cavity carcinoma.  World Molecular Imaging Congress (WMIC), Savannah, GA, P239:September 18-21, 2013.
  10. Warram JM, Mahoney MJ, Zinn KR.  Combined imaging and screening of prostate cancer.  World Molecular Imaging Congress (WMIC), P499:Savannah, GA, September 18-21, 2013.
  11. Korb ML, Samuel S, Killingsworth CR, Dion D, Schoeb TR, Rosenthal EL, Zinn KR. Repeated imaging of cetuximab-IRDye800 in non-human primates. World Molecular Imaging Congress (WMIC), Savannah, GA, SS155:September 18-21, 2013.